Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo

Abstract

Regulation of transgene expression is a major goal of gene therapy research. Previously, we have developed a complex adenovirus (Ad) vector with tetracycline-regulated expression of a Fas ligand (FasL)-green fluorescent protein (GFP) fusion protein. This vector delivered high levels of activity that was regulated by doxycycline. However, this regulation was limited by the low but significant background activity of the TRE promoter. Recently, the Tet-regulated transcriptional silencer, tTS, was reported to suppress efficiently basal TRE activity without affecting induced expression levels. Here, we report development of Ad vectors that incorporate tTS in combination with that of reverse transactivator (rtTA) coupled with TRE promoter driving transgene expression. Incorporation of tTS improved control of transgene expression in vitro, so that an induction range of over three orders of magnitude was achieved in some cell lines. Effective regulation of transgene expression was also seen in a mouse model in vivo, following systemic vector delivery. In the case of FasL-GFP expression, significant improvement in the control of apoptotic activity both in vitro and in a mouse hepatotoxicity model was demonstrated when using rtTA-tTS vectors. In conclusion, a highly effective transgene regulation system, deliverable by a single adenoviral vector, is now available.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Braselmann S, Graninger P, Busslinger M . A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins. Proc Natl Acad Sci USA 1993; 90: 1657–1661.

    Article  CAS  Google Scholar 

  2. Mayo KE, Warren R, Palmiter RD . The mouse metallothionein-I gene is transcriptionally regulated by cadmium following transfection into human or mouse cells. Cell 1982; 29: 99–108.

    Article  CAS  Google Scholar 

  3. Manome Y et al. Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine. Hum Gene Ther 1998; 9: 1409–1417.

    Article  CAS  Google Scholar 

  4. Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547–5551.

    Article  CAS  Google Scholar 

  5. Gossen M et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766–1769.

    Article  CAS  Google Scholar 

  6. Kojima H, Ohishi N, Yagi K . Generation of recombinant adenovirus vector with infectious adenoviral genome released from cosmid-based vector by simple procedure allowing complex manipulation. Biochem Biophys Res Commun 1998; 246: 868–872.

    Article  CAS  Google Scholar 

  7. Smith-Arica JR et al. Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression. Mol Ther 2000; 2: 579–587.

    Article  CAS  Google Scholar 

  8. Tsai SY, Schillinger K, Ye X . Adenovirus-mediated transfer of regulatable gene expression. Curr Opin Mol Ther 2000; 2: 515–523.

    CAS  PubMed  Google Scholar 

  9. Rubinchik S et al. Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system. Gene Therapy 2000; 7: 875–885.

    Article  CAS  Google Scholar 

  10. Takahashi T et al. Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 1994; 6: 1567–1574.

    Article  CAS  Google Scholar 

  11. Orlinick JR, Vaishnaw AK, Elkon KB . Structure and function of Fas/Fas ligand. Int Rev Immunol 1999; 18: 293–308.

    Article  CAS  Google Scholar 

  12. Nagata S . Fas ligand-induced apoptosis. Annu Rev Genet 1999; 33: 29–55.

    Article  CAS  Google Scholar 

  13. Hyer ML et al. Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis. Mol Ther 2000; 2: 348–358.

    Article  CAS  Google Scholar 

  14. Baron U, Bujard H . Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. Methods Enzymol 2000; 327: 401–421.

    Article  CAS  Google Scholar 

  15. Urlinger S et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 2000; 97: 7963–7968.

    Article  CAS  Google Scholar 

  16. Solera J et al. Treatment of human brucellosis with netilmicin and doxycycline. Clin Infect Dis 1996; 22: 441–445.

    Article  CAS  Google Scholar 

  17. Rubinchik S et al. Creation of a new transgene cloning site near the right ITR of Ad5 results in reduced enhancer interference with tissue-specific and regulatable promoters. Gene Therapy 2001; 8: 247–253.

    Article  CAS  Google Scholar 

  18. Gossen M, Bonin AL, Bujard H . Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem Sci 1993; 18: 471–475.

    Article  CAS  Google Scholar 

  19. Freundlieb S et al. Use of tetracycline-controlled gene expression systems to study mammalian cell cycle. Methods Enzymol 1997; 283: 159–173.

    Article  CAS  Google Scholar 

  20. Steinwaerder DS, Lieber A . Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo. Gene Therapy 2000; 7: 556–567.

    Article  CAS  Google Scholar 

  21. Deuschle U, Meyer WK, Thiesen HJ . Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol 1995; 15: 1907–1914.

    Article  CAS  Google Scholar 

  22. Freundlieb S, Schirra-Muller C, Bujard H . A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med 1999; 1: 4–12.

    Article  CAS  Google Scholar 

  23. Margolin JF et al. Kruppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci USA 1994; 91: 4509–4513.

    Article  CAS  Google Scholar 

  24. Rubinchik S, Woraratanadharm J, Schepp J, Dong JY . Improving the transcriptional regulation of genes delivered by adenovirus vectors. Methods Mol Med 2003; 76: 167–199.

    CAS  PubMed  Google Scholar 

  25. Wood M et al. Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Cancer Gene Ther 1999; 6: 367–372.

    Article  CAS  Google Scholar 

  26. Miller N, Whelan J . Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum Gene Ther 1997; 8: 803–815.

    Article  CAS  Google Scholar 

  27. Agha-Mohammadi S, Lotze MT . Regulatable systems: applications in gene therapy and replicating viruses. J Clin Invest 2000; 105: 1177–1183.

    Article  CAS  Google Scholar 

  28. Mizuguchi H et al. Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions. Hum Gene Ther 2003; 14: 1265–1277.

    Article  CAS  Google Scholar 

  29. Howe JR et al. The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J Biol Chem 1995; 270: 14168–14174.

    Article  CAS  Google Scholar 

  30. Wells KD et al. Codon optimization, genetic insulation, and an rtTA reporter improve performance of the tetracycline switch. Transgenic Res 1999; 8: 371–381.

    Article  CAS  Google Scholar 

  31. Mizuguchi H, Hayakawa T . The tet-off system is more effective than the tet-on system for regulating transgene expression in a single adenovirus vector. J Gene Med 2002; 4: 240–247.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Dr James S Norris, Dr H Bujard and Dr Maria Trojanowska for their support. This research was supported by grants from the National Institutes of Health, R01 DK57997, the National Cancer Institute, 1R24 CA82933, and a start up fund provided to Jian-yun (John) Dong by the Medical University of South Carolina.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rubinchik, S., Woraratanadharm, J., Yu, H. et al. New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo. Gene Ther 12, 504–511 (2005). https://doi.org/10.1038/sj.gt.3302437

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302437

Keywords

This article is cited by

Search

Quick links